Nectar Lifescience Ltd vs Oxygenta Pharmaceutical Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Nectar Lifescience Ltd is ₹ 12.4 as of 30 Apr 15:30 . The P/E Ratio of Nectar Lifescience Ltd changed from 21.5 on March 2022 to 0 on March 2025 . This represents a CAGR of -100.00% over 4 yearsThe P/E Ratio of Oxygenta Pharmaceutical Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Nectar Lifescience Ltd changed from ₹ 417.13 crore on March 2021 to ₹ 515.35 crore on March 2025 . This represents a CAGR of 4.32% over 5 yearsThe Market Cap of Oxygenta Pharmaceutical Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The revenue of Nectar Lifescience Ltd for the Dec '25 is ₹ 88.81 crore as compare to the Sep '25 revenue of ₹ 0.74 crore. This represent the growth of 11901% The revenue of Oxygenta Pharmaceutical Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Nectar Lifescience Ltd for the Dec '25 is ₹ 33.53 crore as compare to the Sep '25 ebitda of ₹ -175 crore. This represent the decline of -119% The ebitda of Oxygenta Pharmaceutical Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Nectar Lifescience Ltd changed from ₹ 2.97 crore to ₹ 14.27 crore over 7 quarters. This represents a CAGR of 145.20% The net profit of Oxygenta Pharmaceutical Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of Nectar Lifescience Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Oxygenta Pharmaceutical Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Nectar Lifescience Ltd

Nectar Lifescience Limited was initially incorporated on June 27, 1995 as 'Surya Medicare Limited'.
On March 26, 2004, Company changed the name from 'Surya Medicare Limited' to 'Nectar Lifescience Limited'.
NECLIFE is an integrated pharmaceutical organization, engaged in manufacturing and delivering high quality pharmaceutical products.
It is a global pharmaceutical company specializing in Cephalosporins.
Nectar excels in Cephalosporin APIs production with certified facilities meeting global standards.

About Oxygenta Pharmaceutical Ltd

Oxygenta Pharmaceutical Limited was initially incorporated as S S Organics Private Limited as a private limited Company in 1990.
The Company converted its status to a Public Limited Company in 1993 changing the name to S S Organics Limited.
Further, it was changed to Oxygenta Pharmaceutical Limited in FY 2021-22. The Company was incorporated with the objective of carrying on the business of manufacturing all classes and kinds of Drugs including Pharmaceutical preparation, and Organic Fine Chemicals.
It manufactures a wide range of new generation quinolones, antiasthmatic, antiulcerant, and anti-inflammatory drugs.
The Company has plant located at Medak in Andhra Pradesh. The Company is strong in manufacturing of anti ulcerative and anti bacterial drugs.

FAQs for the comparison of Nectar Lifescience Ltd and Oxygenta Pharmaceutical Ltd

Which company has a larger market capitalization, Nectar Lifescience Ltd or Oxygenta Pharmaceutical Ltd?

Market cap of Nectar Lifescience Ltd is 240 Cr while Market cap of Oxygenta Pharmaceutical Ltd is 200 Cr

What are the key factors driving the stock performance of Nectar Lifescience Ltd and Oxygenta Pharmaceutical Ltd?

The stock performance of Nectar Lifescience Ltd and Oxygenta Pharmaceutical Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Nectar Lifescience Ltd and Oxygenta Pharmaceutical Ltd?

As of May 4, 2026, the Nectar Lifescience Ltd stock price is INR ₹12.4. On the other hand, Oxygenta Pharmaceutical Ltd stock price is INR ₹54.34.

How do dividend payouts of Nectar Lifescience Ltd and Oxygenta Pharmaceutical Ltd compare?

To compare the dividend payouts of Nectar Lifescience Ltd and Oxygenta Pharmaceutical Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.